A Breakthrough Treatment for Ulcerative Colitis


6/1/2016  Asana Medical, Inc. CEO Dr. Christine V. Sapan to Present at 2016 BIO International Convention June 8th

Sapan to Provide Data Findings and Analysis from Company’s Recent Pivotal Preclinical Study MIAMI LAKES, FL – June 1, 2016 […]

5/18/2016  Asana Medical, Inc. Adds Dr. Hal K. Wrigley to Board of Directors

MIAMI LAKES, FL – May 18, 2016 – Asana Medical, Inc., (“Asana,” the “Company”), an emerging life science company focused […]

5/10/2016  Asana Medical, Inc. Announces Closing of $1.2 Million Convertible Promissory Note Offering

MIAMI LAKES, FL – May 10, 2016 – Asana Medical, Inc. (“Asana,” the “Company”) is pleased to announce that it […]

More News →

Asana Medical Inc.

Asana Medical Inc. is focused on providing physicians with the first-in-class non-pharmacological, non-surgical treatment option for patients suffering from gastrointestinal (GI) diseases, including Ulcerative Colitis, Crohn’s Disease, and Rectal Mucositis. Asana’s device, derived from Extracellular Matrix, will set into motion a paradigm shift in the treatment of Inflammatory Bowel Disease (IBD) and other diseases from symptom-based, anti-inflammatory therapies to providing a protective coating to promote tissue healing.

We are a GI-oriented company of highly motivated innovators, doctors, scientists, engineers, entrepreneurs, and professionals that identified an opportunity to apply existing Tissue Engineering Technology in a novel application. This will spark a change in the treatment of IBD and other GI diseases.

Facebook Twitter LinkedIn
Asana Medical Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
tel: (844) 432-7262